BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11156006)

  • 1. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for corticosteroid contact hypersensitivity.
    Boffa MJ; Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Sep; 33(3):149-51. PubMed ID: 8565453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 17. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids.
    Lepoittevin JP; Drieghe J; Dooms-Goossens A
    Arch Dermatol; 1995 Jan; 131(1):31-7. PubMed ID: 7826093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis from tixocortol pivalate in a nasal spray masquerading as infectious complication of sinusitis.
    Bircher AJ; Hirsbrunner P; Tschopp K; Wildermuth V
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):54-6. PubMed ID: 7700614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014.
    Pratt MD; Mufti A; Lipson J; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Zirwas MJ; Fransway AF; Mathias CG; Zug KA; DeLeo VA; Fowler JF; Marks JG; Storrs FJ; Belsito DV
    Dermatitis; 2017; 28(1):58-63. PubMed ID: 28002236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.